テンペスト・セラピューティクスのニュース一覧

Tempest Therapeutics Is Maintained at Overweight by Piper Sandler

Dow Jones2024/11/14 01:00

パイパー・サンドラーはテンペスト・セラピューティクス(TPST.US)のレーティングを強気に据え置き、目標株価を5ドルに引き下げた

Futuニュース2024/11/13 21:34

Tempest Therapeutics Analyst Ratings

Benzinga2024/11/13 20:26

HC Wainwright & Co. Reiterates Buy on Tempest Therapeutics, Maintains $47 Price Target

Benzinga2024/11/13 20:26

HC Wainwright & Co. Reiterates Buy on Tempest Therapeutics, Maintains $47 Price Target

Benzinga2024/10/11 01:42

Tempest Therapeutics Analyst Ratings

Benzinga2024/10/11 01:42

スコシアバンクはテンペスト セラピューティクス(TPST.US)のレーティングを強気に据え置き、目標株価を13ドルに据え置いた

Futuニュース2024/08/16 20:34

HC Wainwright & Co. Reiterates Buy on Tempest Therapeutics, Maintains $47 Price Target

Benzinga2024/08/16 00:45

Tempest Therapeutics Analyst Ratings

Benzinga2024/08/16 00:44

HC Wainwright & Co. Reiterates Buy on Tempest Therapeutics, Maintains $47 Price Target

Benzinga2024/06/20 23:23

Tempest Therapeutics Analyst Ratings

Benzinga2024/05/13 20:05

HC Wainwright & Co. Reiterates Buy on Tempest Therapeutics, Maintains $47 Price Target

Benzinga2024/05/13 20:05

Tempest Therapeutics Analyst Ratings

Benzinga2024/05/11 03:00

HC Wainwright & Co. Reiterates Buy on Tempest Therapeutics, Maintains $47 Price Target

Benzinga2024/05/11 03:00

Tempest Therapeutics Analyst Ratings

Benzinga2024/03/20 18:40

HC Wainwright & Co. Reiterates Buy on Tempest Therapeutics, Maintains $47 Price Target

Benzinga2024/03/20 18:40

Scotiabank Initiates Tempest Therapeutics With Sector Outperform Rating, Price Target Is $13

MT Newswires2024/03/14 20:08

Tempest Therapeutics Analyst Ratings

Benzinga2024/03/14 05:25

Scotiabank Initiates Coverage On Tempest Therapeutics With Sector Outperform Rating, Announces Price Target of $13

Benzinga2024/03/14 05:25

Tempest Therapeutics Analyst Ratings

Benzinga2024/03/12 23:05